Medical Imaging Drugs Advisory Committee Will Phase Out By March 2004
This article was originally published in The Gray Sheet
Executive Summary
FDA's Medical Imaging Drugs and Pharmacy Compounding advisory committees will terminate after their charters expire in February 2004